Nova Tina Susan

Azenta, Inc. (AZTA) · Director

Nova Tina Susan is listed in filings as Director at Azenta, Inc. (AZTA). This profile follows SEC Form 4 activity through Feb 6, 2026, including 5 public disclosures. Recent filings connect the profile to Azenta, Inc. (AZTA) (AZTA), Exagen Inc. (XGN), and Aurinia Pharmaceuticals Inc. (AUPH). The current snapshot covers public activity from Jun 12, 2024 to Feb 6, 2026. Reported amounts are shown as $157.7K to $519.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.